Levomed (Carbidopa, Levodopa)

Carbidopa/Levodopa, the active ingredient in Levomed, is an Antiparkinson agent presented as an oral tablet formulation for oral use. It is used to treat Parkinson's disease and Parkinsonian syndrome by restoring dopamine levels in the brain. GNH USA supplies Levomed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levomed, a combination of carbidopa and levodopa, is employed in the management of movement disorders related to dopamine deficiency. - Parkinson's disease: improves motor symptoms such as bradykinesia, rigidity and tremor. - Parkinsonian syndrome: alleviates similar motor deficits caused by secondary or atypical Parkinsonism.

Levomed may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea or vomiting - Dizziness or light‑headedness - Orthostatic hypotension - Headache - Insomnia or vivid dreams - Dyskinesia (involuntary movements)

Serious or Rare Side Effects: - Hallucinations or severe psychiatric changes - Severe hypotension or syncope - Cardiac arrhythmias - Neuroleptic malignant syndrome - Severe allergic reactions (rash, swelling, anaphylaxis) - Hyperpyrexia or severe muscle rigidity

When prescribing Levomed, clinicians should consider several safety measures. - Monitor blood pressure: watch for orthostatic drops, especially after dose initiation. - Assess psychiatric status: be alert for hallucinations, confusion or mood changes. - Adjust dose in renal impairment: reduced clearance may increase exposure. - Avoid abrupt discontinuation: taper to prevent withdrawal and worsening of symptoms. - Use with caution in elderly patients: increased sensitivity to side effects. - Store at ambient temperature: keep below 25°C in the original packaging, protected from moisture.

Levomed can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Non‑selective MAO inhibitors (e.g., phenelzine) – risk of hypertensive crisis. - Antipsychotics that block dopamine receptors – may diminish therapeutic effect. - Pyridoxine (vitamin B6) high doses – accelerates peripheral levodopa metabolism.

Moderate Interactions (Monitor Closely): - Antihypertensive agents – additive blood pressure lowering. - Selective serotonin reuptake inhibitors – potential serotonin syndrome. - Iron or calcium supplements – may reduce levodopa absorption if taken simultaneously. - Other antiparkinson drugs (e.g., MAO‑B inhibitors) – may require dose adjustments.